Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyMyelomaTeam Member asked a question 💭
Rhinelander, WI

I have MGUS at this time

March 1
 · 
Reactions
A MyMyelomaTeam Member

Mark,
Most people with MGUS progress in 20-30 years, unless they are high risk. Ask your doctor what your risk of progression is.
Paula🌹

March 1
A MyMyelomaTeam Member

Tina and I hope your doing well! Yes, I did see the latest approval. Thanks!

March 2
A MyMyelomaTeam Member

Hi Mark
I think they just approved Darzlex Faspro for smoldering multiple myeloma. Your Hematologist Oncologist should be able to guide you through this. Tell Tina I said Hello.

March 2
MyMyelomaTeam

What treatment options are available for smoldering multiple myeloma (SMM)?

For smoldering multiple myeloma, the approach depends on your risk level. Traditionally, doctors recommended "watchful waiting" - regular monitoring through follow-up visits and testing without immediate treatment. This allows you to avoid Show Full Answer

What treatment options are available for smoldering multiple myeloma (SMM)?

For smoldering multiple myeloma, the approach depends on your risk level. Traditionally, doctors recommended "watchful waiting" - regular monitoring through follow-up visits and testing without immediate treatment. This allows you to avoid treatment side effects while catching any progression early.

However, recent evidence suggests that early treatment may improve outcomes, especially for high-risk SMM. Here are the current options:

Watchful Waiting (Active Surveillance)
- Regular monitoring with periodic tests and examinations
- No immediate treatment, avoiding side effects
- Appropriate for lower-risk cases

Bone-Strengthening Medications
Some people with SMM take bisphosphonates to protect against bone damage:
- Aredia (pamidronate)
- Xgeva (denosumab)
- Zometa (zoledronic acid)

Early Treatment for High-Risk SMM
Clinical trials have shown that certain medications may reduce the chances of developing active myeloma:
- Revlimid (lenalidomide)
- Low-dose Decadron (dexamethasone)

Early treatment is particularly recommended when you have specific high-risk features, such as high levels of M protein in your blood or plasma cells with certain genetic characteristics that indicate higher risk of progression.

Your doctor will help determine which approach is best based on your individual risk factors and test results.

March 1

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In